What is Denvax treatment?
What is Denvax treatment?
The DENVAX is dendritic cell based cancer immunotherapy for solid cancers in various stages of the disease. It is autologous treatment, which involves patient’s own mononuclear cells transformed into cancer-specific dendritic cells.
What is the cost of immunotherapy in India?
The minimum cost of one cycle is Rs 1 lakh and can go up to the maximum cost of Rs 4 lakh as they are patent drugs. Each cycle has to be repeated in 21 days depending on the recovery that has been seen.
Is immunotherapy a cure?
Not a cure, but an extension: How immunotherapy works for advanced lung cancer. Immunotherapy doesn’t usually cure advanced lung cancer, but it can give some patients more time with family and friends. For nearly five decades, doctors have used various forms of immunotherapy to treat certain cancers.
Who is the pioneer of dendritic cell therapy in India?
She came to know of Dr. Jamal A. Khan, cancer immunotherapist, pioneer of Dendritic cell therapy in India. Dr. Khan MBBS, MD who has treated over a thousand patients till date, discussed the cancer treatment plan with her. He put her on low-dose gemcitabine chemotherapy along with DENVAX -dendritic cell therapy.
What is dendritic cell immunotherapy?
DENVAX. The DENVAX is dendritic cell based cancer immunotherapy for solid cancers in various stages of the disease. It is autologous treatment, which involves patient’s own mononuclear cells transformed into cancer-specific dendritic cells. Designed to be specific, DENVAX targets only the cancer cells without harming the healthy ones.
Who is Jamal a Khan?
Dr. Jamal A. Khan has been a researcher and teaching faculty at the Jawaharlal Nehru Medical College at Aligarh Muslim University, from 1997 till 2005. He left his job to pursue his research interest in immunology and more particularly, cancer. He set out to develop a treatment modality for cancer patients based on revival of immunology.
What are dendritic cells (DC)?
DENDRITIC CELLS (DC) are the key ANTIGEN PRESENTING CELLS (APC) of the immune system. They are the cells that INITIATE, DIRECT and REGULATE the immune responses. The DENVAX is dendritic cell based cancer immunotherapy for solid cancers in various stages of the disease.
